GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Guizhou Xinbang Pharmaceutical Co Ltd (SZSE:002390) » Definitions » ROCE %

Guizhou Xinbang Pharmaceutical Co (SZSE:002390) ROCE % : 5.84% (As of Sep. 2024)


View and export this data going back to 2010. Start your Free Trial

What is Guizhou Xinbang Pharmaceutical Co ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Guizhou Xinbang Pharmaceutical Co's annualized ROCE % for the quarter that ended in Sep. 2024 was 5.84%.


Guizhou Xinbang Pharmaceutical Co ROCE % Historical Data

The historical data trend for Guizhou Xinbang Pharmaceutical Co's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Guizhou Xinbang Pharmaceutical Co ROCE % Chart

Guizhou Xinbang Pharmaceutical Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
ROCE %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 9.08 6.91 8.62 5.22 6.10

Guizhou Xinbang Pharmaceutical Co Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
ROCE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 7.69 3.77 4.79 5.16 5.84

Guizhou Xinbang Pharmaceutical Co ROCE % Calculation

Guizhou Xinbang Pharmaceutical Co's annualized ROCE % for the fiscal year that ended in Dec. 2023 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: Dec. 2023 )  (A: Dec. 2022 )(A: Dec. 2023 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: Dec. 2023 )  (A: Dec. 2022 )(A: Dec. 2023 )
=435.72/( ( (9793.503 - 2686.811) + (9244.971 - 2058.569) )/ 2 )
=435.72/( (7106.692+7186.402)/ 2 )
=435.72/7146.547
=6.10 %

Guizhou Xinbang Pharmaceutical Co's ROCE % of for the quarter that ended in Sep. 2024 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: Sep. 2024 )  (Q: Jun. 2024 )(Q: Sep. 2024 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Sep. 2024 )  (Q: Jun. 2024 )(Q: Sep. 2024 )
=416.644/( ( (9005.185 - 1884.423) + (8896.669 - 1758.88) )/ 2 )
=416.644/( ( 7120.762 + 7137.789 )/ 2 )
=416.644/7129.2755
=5.84 %

(1) Note: The EBIT data used here is four times the quarterly (Sep. 2024) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Guizhou Xinbang Pharmaceutical Co  (SZSE:002390) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.


Guizhou Xinbang Pharmaceutical Co ROCE % Related Terms

Thank you for viewing the detailed overview of Guizhou Xinbang Pharmaceutical Co's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.


Guizhou Xinbang Pharmaceutical Co Business Description

Traded in Other Exchanges
N/A
Address
6th Floor, Kekai 1st Court, Intersection of Aerospace Avenue and Xintian Avenue, Wudang District, Guiyang, CHN
Guizhou Xinbang Pharmaceutical Co Ltd is a China-based pharmaceutical company. The company is engaged in providing medical services and pharmaceutical distribution. The scope of business also covers the cultivation of Chinese herbal medicines, production of Chinese herbal medicines and Chinese patent medicines, research and development, production and sales of biological drugs, and other fields.
Executives
An Ji Director
Gao Wen Lin Executives
Lu Ya Fang Executives
Xu Qi Directors, executives
An Huai Lve Director
Ma Cheng Director
Zhang Jie Qing Directors, executives
Kong Ling Zhong Directors, executives
Liu Xiao Yang Executives
Xiao Ya Yun Executives
Yang Pei Executives
Zhang Guan Fu Director
Chen Chuan Directors, executives
He Wen Jun Supervisors
Lv Yu Tao Director

Guizhou Xinbang Pharmaceutical Co Headlines

No Headlines